Module 1 special populations Flashcards
pregnancy
research is lacking medications cross placenta trimester matters teratogenic effects benefit/risk
pediatrics
meds can impact long-term growth and development
weight based dosing
route-based decision making
common problems in geriatric patients
immobility isolation impaired senses inadequate nutrition immunodeficiency instability
geriatrics and absorption
- slower gastric emptying and dec. gastric acid -> variable absorption
- dec. blood flow to muscles and subQ fat -> unpredictable absorption of IM and subQ meds
geriatrics and distribution
- inc. risk dehydration
- dec. albumin production -> dec. protein binding -> inc. Vd
- lower body water -> dec. Vd for hydrophilic drugs
- inc. body fat and dec. muscle -> larger Vd for lipophilic drugs
- half-life and loading doses change
geriatrics and metabolism
liver function dec.
inc. potential for drug interactions
co-morbid diseases
poor nutrition
excretion and geriatrics
dec. renal function
need to calculate creatinine clearance or GFR when dosing drugs
pharmacodynamic changes in geriatrics
changes in receptor binding affinity, up-regulation, or down regulation
- dec. CO and vascular changes
- exaggerated hypotension is common
- inc. risk bradycardia or tachyarrhythmias
obesity and pharmacokinetics
inc. lipophilic Vd
drug doses off of ideal body weight, not total body weight
classification of BMI
underweight: <18.5 normal weight: 18.5-24.9 overweight: 25.9-29.9 obesity 1: 30.0-34.9 obesity 2: 35.0-39.9 obesity 3: >40
obesity and hydrophilic drugs
will distribute to the muscle compartment
- if loading dose needed, use lean body mass
obesity and lipophilic drugs
will distribute to fat
have larger Vd in obese patients
loading doses should be dosed by ideal body weight
drug toxicity and on-target effects
drug binds to intended receptor but in the wrong tissue or at an inappropriate concentration
drug toxicity and off-target effect
drug binds to wrong receptors
idiosyncratic toxicity
rare event with no obvious mechansim